OS Therapies Incorporated (OSTX) Stock Forecast
Data as of May 6, 2026Healthcare · Current price $1.71 (+2.71%)
Consensus Target
—
Upside
—
Analysts
12
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy4
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
OSTX vs Sector & Market
| Metric | OSTX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 12 | 8 | 18 |
| Target Upside | — | +1148.8% | +14.9% |
| P/E Ratio | -1.66 | 6.76 | 31.56 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6M | $7M | $9M | 3 |
| 2027-12-31 | $16M | $20M | $24M | 2 |
| 2028-12-31 | $28M | $36M | $44M | 3 |
| 2029-12-31 | $40M | $51M | $62M | 2 |
| 2030-12-31 | $169M | $217M | $260M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.71 | $-0.58 | $-0.44 | 3 |
| 2027-12-31 | $-0.40 | $-0.32 | $-0.23 | 2 |
| 2028-12-31 | $-0.16 | $-0.03 | $0.24 | 3 |
| 2029-12-31 | $0.04 | $0.05 | $0.07 | 1 |
| 2030-12-31 | $1.55 | $2.18 | $2.75 | 1 |
Frequently Asked Questions
What is the analyst consensus for OSTX?
The consensus among 12 analysts covering OS Therapies Incorporated (OSTX) is Buy with an average price target of N/A.
How many analysts cover OSTX?
12 analysts have issued ratings for OS Therapies Incorporated in the past 12 months.
Is OSTX a buy or sell right now?
Based on 12 analyst ratings, OSTX has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for OSTX?
Analysts estimate OSTX will report EPS of $-0.58 for the period ending 2026-12-31, with revenue estimated at $7M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.